Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Jitendra Patil | Health Sciences | Best Researcher Award

Published on by Research Awards

Mr. Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Sankalchand Patel University Visnagar,Badoda | India

Mr. Jitendra Hilal Patil, Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, is a PCI-registered academic with a strong background in pharmaceutical sciences and nanotechnology. He holds an M.Pharm in Quality Assurance and is pursuing his Ph.D. at Sankalchand Patel University, Visnagar. His research focuses on developing pH-responsive nanocarrier drug delivery systems for targeted cancer therapy, with publications in Scopus-indexed journals and one patent under process. With a citation index of 29, his innovative work contributes significantly to advancing precision medicine while minimizing systemic toxicity in anticancer treatments.

Author Profile 

Scopus

Education

From the very beginning of his educational journey, Mr. Jitendra Hilal Patil demonstrated a keen interest in pharmaceutical sciences and biomedical research. His strong academic foundation was built through consistent excellence across secondary and higher secondary education, which he pursued with dedication and discipline. His pursuit of a Bachelor’s and Master’s degree in Pharmacy further sharpened his knowledge in drug formulation, quality assurance, and advanced pharmaceutical principles. These formative academic years not only shaped his scientific mindset but also ignited his passion for research in nanotechnology and innovative drug delivery systems. His pursuit of a Ph.D. reflects his commitment to expanding the boundaries of knowledge and contributing to global healthcare challenges.

Experience

Mr. Patil serves as a Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, where he plays a pivotal role in nurturing future pharmacists and researchers. His teaching approach integrates theory with practical insights, encouraging students to think critically about real-world healthcare challenges. Alongside his teaching responsibilities, he actively engages in research, ensuring his academic contributions are aligned with the latest developments in pharmaceutical innovation. His ability to balance teaching, research, and mentoring highlights his versatility as both an educator and a researcher. He also ensures his students are exposed to cutting-edge topics such as nanotechnology, targeted therapies, and drug delivery systems, preparing them to excel in the evolving landscape of pharmaceutical sciences.

Research Focus

The hallmark of Mr. Patil’s academic journey lies in his research on pH-responsive nanocarrier drug delivery systems designed for targeted cancer treatment. Recognizing the limitations of conventional chemotherapy—such as poor survival rates, systemic toxicity, and severe side effects—he focused on developing titanium-based metal-organic frameworks (Ti-MOFs) as nanocarriers for the anticancer drug axitinib (AXT).

Through advanced hydrothermal synthesis and characterization techniques, he successfully developed stable, porous nanostructures that exhibit excellent pH-responsive behavior. His in vitro studies revealed that these carriers released minimal drug amounts in neutral pH, simulating healthy tissues, but significantly increased release in acidic environments mimicking cancer cells. This innovation represents a major step toward precision medicine, offering the potential to reduce toxicity and enhance therapeutic efficacy. His work exemplifies how nanotechnology can transform oncology treatments, opening doors to more effective and patient-friendly therapies.

Awards and Recognition

Mr. Patil’s research has garnered recognition through Scopus-indexed publications, citations, and a patent under process, highlighting the originality and applicability of his work. With a citation index of 29, his publications demonstrate a meaningful academic impact and a growing influence in the pharmaceutical research community. He is also a registered member of the Pharmacy Council of India (PCI), further strengthening his professional credibility. While he has not yet accumulated multiple industry consultancy projects or editorial appointments, his promising work and contributions reflect the qualities of a rising researcher who is set to achieve even greater recognition at both national and international levels.

Impact and Influence

The potential impact of Mr. Patil’s research extends beyond academia, offering transformative possibilities in cancer treatment. By addressing the challenges of drug toxicity and inefficient targeting, his nanocarrier-based system has the potential to improve the quality of life for patients undergoing therapy. Moreover, his contributions set a strong foundation for future collaborations in nanomedicine, oncology research, and pharmaceutical technology. His influence also extends to his students, who benefit from his mentorship, guidance, and emphasis on research-driven learning. By bridging the gap between classroom knowledge and practical innovation, he inspires a new generation of pharmaceutical professionals to pursue impactful research that addresses pressing healthcare challenges.

Publications

Nonlocal thermoelastic diffusion analysis in a semi-infinite body subjected to thermal loading with memory effects.

Author: Jitendra Patil, Chandrakant Jadhav, Nitin Chandel & Vinod Varghese
Journal: Archive of Applied Mechanics
Year: 2025

Development and Characterization of AXT@Metal-Organic Framework: A Biocompatible, pH-Responsive Nanocarrier for Targeted Axitinib Delivery in MCF-7 Cancer Cells.

Author: Jayvadan K. Patel, Ujashkumar A. Shah, Pravin O. Patil, Jitendra H. Patil
Journal: Annales Pharmaceutiques Françaises
Year: 2025

Conclusion

Mr. Jitendra Hilal Patil exemplifies the qualities of a dedicated educator, an emerging researcher, and an innovator in pharmaceutical sciences. His academic journey, professional commitments, and research on pH-responsive nanocarriers reflect not only his scientific expertise but also his vision for improving global healthcare outcomes. With a growing body of impactful publications, a patent under process, and recognition as a promising voice in nanotechnology and drug delivery research, he continues to inspire both peers and students alike. Looking forward, his unwavering dedication positions him to make enduring contributions that bridge cutting-edge research with tangible benefits for society, leaving a meaningful legacy in academia and beyond.

Cheng Ni | Health Sciences | Best Researcher Award | 13442

Published on by Research Awards

Prof. Cheng Ni | Health Sciences | Best Researcher Award

Prof. Cheng Ni, Cancer Hospital, Chinese Academy of Medical Sciences, China

Prof. Cheng Ni, M.D., Ph.D. is a Professor and Consultant Anesthesiologist at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, where he also serves as Associate Chief of the Department of Anesthesiology. With extensive clinical and academic experience in thoracic anesthesiology, perioperative neuroprotection, and cancer pain management, Prof. Ni has held key roles at leading institutions including Peking University and Harvard University. His research focuses on perioperative neurocognitive disorders, tumor immunology, and the application of AI in anesthesiology. He has published over 50 SCI-indexed articles and holds 11 authorized patents.

Profile

Scopus

🎓 Early Academic Pursuits

Prof. Cheng Ni’s academic journey is a testament to dedication and intellectual rigor. He began his medical education at Capital Medical University, earning his M.D. in 2003 and M.S. in 2005, laying a solid foundation in medical sciences. His passion for deeper understanding and specialization led him to pursue a Ph.D. at Peking University, one of China’s most prestigious institutions, which he completed in 2012. This advanced academic training equipped him with a rich knowledge base in anesthesiology and related biomedical sciences, paving the way for a distinguished career in clinical practice, teaching, and research.

🩺 Professional Endeavors

Prof. Ni’s professional career reflects a steady and impactful rise through China’s top-tier medical institutions. He began as a Resident at Peking University Third Hospital (2005–2008) and subsequently served as an Attending Anesthesiologist (2008–2015). During this period, he gained hands-on clinical experience and honed his leadership abilities.

In 2013–2014, he expanded his global perspective as a Postdoctoral Research Fellow at Harvard University, engaging with cutting-edge international research. Upon his return, he held several key administrative and academic roles at Peking University, including Chief Secretary of the Faculty of Anesthesiology, and Associate Consultant and Associate Professor.

In 2020, Prof. Ni joined the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, a top national institution, as a Consultant and Associate Professor. His expertise quickly earned him leadership roles as Associate Chief of the Department of Anesthesiology, and by 2021, he was promoted to Professor and Consultant. He also became a Ph.D. Supervisor in 2023, mentoring the next generation of clinical researchers and specialists.

🔬 Contributions and Research Focus

Prof. Ni’s research contributions span multiple high-impact areas in modern anesthesiology and cancer care. His primary interests include:

  • Perioperative neurocognitive disorders 🧠

  • Thoracic anesthesiology and neuroprotection 💨🛡️

  • Cancer pain management 🧬

  • Genetics and tumor immunology 🧫

  • AI in anesthesiology research 🤖🩺

He has authored over 50 peer-reviewed articles in leading SCI-indexed journals, including Aging Cell, CNS Neuroscience & Therapeutics, Life Sciences, and Anesthesia & Analgesia. His recent publications explore the neuroinflammatory response during surgery, the effects of anesthesia on brain aging, and the integration of hybrid learning models for brain cell identification—blending medical science with artificial intelligence.

In addition to journal publications, Prof. Ni has contributed to 12 academic monographs and holds 11 authorized patents, underscoring his commitment to translational research and innovation.

🏅 Accolades and Recognition

Prof. Cheng Ni is widely respected in China’s medical and academic communities. His achievements have been recognized through his appointment to senior roles such as:

  • Chief Secretary of Anesthesiology Faculty, Peking University Health Science Center

  • Associate Chief of the Department of Anesthesiology at China’s National Cancer Center

  • Ph.D. Supervisor, guiding graduate-level research and fostering academic excellence

These appointments are not only acknowledgments of his skill and dedication but also affirmations of his influence in shaping anesthesiology and cancer care practices in China.

🌍 Impact and Influence

Prof. Ni’s work resonates far beyond the operating room. His integration of AI into anesthesiology research marks a forward-thinking approach to modern medicine. By exploring the cognitive effects of anesthesia, he contributes to improving surgical outcomes and patient safety, particularly in aging populations.

His leadership and mentorship roles at premier institutions like Peking University and the Cancer Hospital, CAMS, have helped nurture a generation of professionals equipped with both technical excellence and ethical insight.

Furthermore, his international collaboration with Harvard University has brought valuable cross-cultural research experience into Chinese clinical research settings, promoting a global standard in anesthesiology and perioperative medicine.

🌱 Legacy and Future Contributions

Looking ahead, Prof. Ni is poised to play a pivotal role in shaping the future of anesthesiology in cancer care. His continued emphasis on neuroprotection, chronic pain management, and artificial intelligence applications signals a progressive vision aligned with global health priorities.

As a Ph.D. supervisor and seasoned educator, his mentorship will continue to inspire emerging scholars. His innovations in clinical protocols and diagnostic tools will likely set new benchmarks in anesthetic safety and cancer patient recovery.

Prof. Cheng Ni stands as a bridge between tradition and innovation, combining deep clinical knowledge with research excellence to lead transformative change in anesthesiology and oncology care.

Publication Top Notes

Aged hippocampal single-cell atlas screening unveils disrupted neuroglial system in postoperative cognitive impairment

Author: Z., Suo, Zizheng, T., Xiao, Ting, Y., Qu, Yinyin, … H., Zheng, Hui, C., Ni, Cheng
Journal: Aging Cell
Year: 2025

Year: 2024

 

RAGHURAM SHYAMSUNDER RAO | Health Specialist | Best Researcher Award

Published on by Research Awards

Dr. RAGHURAM SHYAMSUNDER RAO | Health Specialist | Best Researcher Award 

Assistant Director General at Central TB Division, Dept of Health, Ministry of Health & Family Welfare, Government of India, India

Dr. Raghuram Rao, the Assistant Director General of the Central TB Division in the Department of Health, Ministry of Health & Family Welfare, Government of India, is a seasoned Public Health Specialist with over 22 years of experience. His expertise spans managing communicable diseases such as TB, Leprosy, and HIV, and he has significantly contributed to public health program implementation, climate change, environmental health, and bio-medical waste management. In his current role, Dr. Rao leads epidemiology, surveillance, World Bank and Global Fund projects, Ni-kshay digital health innovations, policy and planning, and the integration of TB services into the general health system. His research interests include communicable diseases, public health program implementation, and environmental health. Dr. Rao has authored multiple research publications in peer-reviewed national and international journals. His research skills include leading epidemiological studies, implementing large-scale health programs, and utilizing digital health innovations for public health improvements. 📊🩺

Professional Profiles:

🎓 Education

Dr. Raghuram Rao has a robust educational background in public health, which has laid the foundation for his extensive work in the field. He holds a degree in Public Health, specializing in communicable diseases. His academic journey has equipped him with the knowledge and skills necessary to address complex public health challenges, particularly in the areas of TB, Leprosy, and HIV. Through continuous learning and professional development, Dr. Rao has remained at the forefront of public health advancements, contributing significantly to the implementation of health programs and research initiatives. 📘🔬🌐

Professional Experience

Dr. Raghuram Rao serves as the Assistant Director General at the Central TB Division, Dept of Health, Ministry of Health & Family Welfare, Government of India. With around 22 years of experience in public health, he has focused on communicable diseases such as TB, Leprosy, and HIV. His work extends to public health program implementation, Climate Change & Environmental Health, and Bio-medical Waste Management. In his current role, Dr. Rao leads epidemiology, surveillance, World Bank & Global Fund projects, Ni-kshay, digital health innovations, policy & planning, and the integration of TB services into the general health system. His dedication to public health is further demonstrated by his extensive research contributions in peer-reviewed national and international journals. 🩺📊🌍

Research Interest

Dr. Raghuram Rao’s research interests lie primarily in public health, with a focus on communicable diseases such as TB, Leprosy, and HIV. He is passionate about the implementation and impact of public health programs and policies. Dr. Rao’s work also extends to the fields of Climate Change & Environmental Health and Bio-medical Waste Management, where he explores the intersections between environmental factors and public health outcomes. His interest in epidemiology and surveillance is evident through his leadership in various projects under the World Bank and Global Fund. Additionally, Dr. Rao is keen on digital health innovations and their potential to revolutionize disease monitoring and health service delivery. His numerous publications in national and international peer-reviewed journals reflect his commitment to advancing knowledge in these critical areas of public health. 🌍📈💡

Award and Honors

Dr. Raghuram Rao has been recognized for his exceptional contributions to public health with numerous awards and honors. His dedication to combating communicable diseases such as TB, Leprosy, and HIV has earned him accolades from various national and international bodies. Dr. Rao’s innovative work in integrating digital health solutions into TB surveillance and management has been particularly celebrated. His leadership in World Bank and Global Fund projects has also garnered recognition, showcasing his ability to manage large-scale public health initiatives effectively. Additionally, Dr. Rao’s commitment to research and his extensive publication record in esteemed journals highlight his impact on the academic and professional community. His contributions to Climate Change & Environmental Health and Bio-medical Waste Management have further solidified his reputation as a versatile and influential public health specialist. 🌟🌍📜

Research Skills

Dr. Raghuram Rao possesses a comprehensive set of research skills honed over his 22 years in public health. He excels in epidemiology and surveillance, crucial for tracking and managing communicable diseases like TB, Leprosy, and HIV. Dr. Rao’s proficiency in policy and planning enables him to develop and implement effective health programs. His experience with World Bank and Global Fund projects demonstrates his capability in managing large-scale, international research initiatives. Dr. Rao is also skilled in integrating digital health innovations, such as Ni-kshay, to enhance TB service delivery and data management. His research has been widely published in peer-reviewed national and international journals, reflecting his ability to conduct rigorous scientific investigations. Additionally, Dr. Rao’s work in Climate Change & Environmental Health and Bio-medical Waste Management underscores his versatility and commitment to addressing diverse public health challenges. 🌐📊🩺

Publications

  1. Title: Need for operational simplicity and timely disbursal of benefits—a qualitative exploration of the implementation of a direct benefit transfer scheme for persons with tuberculosis in India
    • Authors: Mohan, M., Thangaraj, J.W.V., Pandey, S., Murhekar, M.V., Jeyashree, K.
    • Year: 2024
    • Journal: Infectious Diseases of Poverty
  2. Title: Direct benefit transfer for nutritional support of patients with TB in India—analysis of national TB program data of 3.7 million patients, 2018–2022
    • Authors: Jeyashree, K., Shanmugasundaram, P., Shanmugasundaram, D., Mattoo, S.K., Murhekar, M.V.
    • Year: 2024
    • Journal: BMC Public Health
  3. Title: Automatic Interpretation of Line Probe Assay Test for Tuberculosis
    • Authors: Agrawal, J., Kumar, M., Tiwari, A., Anand, S., Kumar, N.
    • Year: 2024
    • Journal: Proceedings of the AAAI Conference on Artificial Intelligence
  4. Title: Differentiated TB care: Tamil Nadu’s achievements, plans and implications for national TB programmes
    • Authors: Shewade, H.D., Frederick, A., Suma, K.V., Ramachandran, R., Murhekar, M.V.
    • Year: 2024
    • Journal: International Journal of Tuberculosis and Lung Disease
  5. Title: Sex-disaggregated patterns in tuberculosis treatment coverage and outcomes among a nationally representative sample of deaths in India: 2019–2022
    • Authors: Dandona, R., Kumar, G.A., Dora, S.S.P., Dandona, L., Rao, R.
    • Year: 2024
    • Journal: The Lancet Regional Health – Southeast Asia
  6. Title: Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey
    • Authors: Giridharan, P., Selvaraju, S., Rao, R., Gangakhedkar, R.R., Bhargava, B.
    • Year: 2023
    • Journal: PLoS ONE
  7. Title: Prevalence and factors associated with tuberculosis infection in India
    • Authors: Selvaraju, S., Velayutham, B., Rao, R., Panda, S., Bhargava, B.
    • Year: 2023
    • Journal: Journal of Infection and Public Health
  8. Title: Mortality estimates of central nervous system TB in India
    • Authors: Inbaraj, L.R., Rade, K., Selvaraju, S., Rao, R.
    • Year: 2023
    • Journal: International Journal of Tuberculosis and Lung Disease
  9. Title: Estimating the Burden of Tuberculosis in India: A Modelling Study
    • Authors: Mandal, S., Rao, R., Joshi, R.
    • Year: 2023
    • Journal: Indian Journal of Community Medicine
  10. Title: Patient adherence to tuberculosis treatment in the Indian subcontinent: Systematic review and meta-synthesis of qualitative research
    • Authors: Shringarpure, K., Gurumurthy, M., Sagili, K.D., Rao, R., Sachdeva, K.S.
    • Year: 2023
    • Journal: BMJ Open

 

Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Mojtaba Aghaei | Medicine and Health Sciences | Best Researcher Award

Dr Mojtaba Aghaei, Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Iran

Mojtaba Aghaei is a Master of Science and Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Iran. 🌟 Specializing in Hematology, Blood Banking, Cancer Therapy, and Cell Signaling, Mojtaba’s research focuses on genetic variants, diabetes mellitus, and chronic lymphoblastic leukemia. 🧬 His projects include systematic reviews and meta-analyses on topics such as advanced glycation end products in PCOS, and the impact of sulfur dioxide on semen quality. With 50 citations and ongoing research on ischemia-modified albumin, his work advances understanding in hematology and endocrinology. 📊🔬

Publication profile

Google scholar

Academic and Professional 

Mojtaba Aghaei is a Research Assistant at the Thalassemia & Hemoglobinopathy Research Center, specializing in Hematology, Blood Banking, and Cancer Therapy. His expertise extends to Cancer Cell Signaling, Flow Cytometry, Cell Culture, Endocrinology, and Gynecology.

Research Projects

Recent studies have explored various aspects of health and disease through systematic reviews and meta-analyses. 🧬 Key areas include the impact of genetic variants on antifungal immunity in hematologic malignancies, associations between Galectin-3 and gestational diabetes, and the role of advanced glycation end products in polycystic ovary syndrome (PCOS). 🔬 Research also investigates the effects of environmental pollutants on semen quality and the influence of biomarkers like Pro-BNP on cardiac health. 📊 Additionally, studies address the correlation between eosinophils and IgE in asthma, and factors influencing acute chest syndrome and thrombotic purpura in sickle cell disease. 🌍💉

Research focus

Based on the provided publications, the research focus of SS Bahreiny appears to be on reproductive health, particularly in the context of polycystic ovary syndrome (PCOS) and male fertility. The systematic reviews and meta-analyses span various aspects, such as oxidative stress, hormonal imbalances, and genetic factors related to PCOS, as well as environmental influences on semen quality. This research aims to understand and improve the diagnosis and treatment of reproductive disorders through comprehensive analyses of circulating biomarkers and environmental impacts. 🧬🔬🩺

Publication top notes

Association of free radical product and polycystic ovary syndrome: A systematic review and meta-analysis

Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis

Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis

The influence of CDKAL1 (rs7754840) gene polymorphism on susceptibility to gestational diabetes mellitus in pregnant women: A systematic review and meta-analysis

Association between ambient particulate matter and semen quality parameters: a systematic review and meta-analysis

Exploring the relationship between ambient sulfur dioxide and semen quality parameters: A systematic review and meta-analysis

Circulating levels of advanced glycation end products in females with polycystic ovary syndrome: a meta-analysis

Genetic Variants of Dectin-1 and their antifungal immunity impact in Hematologic Malignancies: A Comprehensive Systematic Review

A closer look at Galectin-3: its association with gestational diabetes mellitus revealed by systematic review and meta-analysis

 

Tugba Agbal | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Ms. Tugba Agbal | Medicine and Health Sciences | Best Researcher Award

Specialist Doctor at Ankara Etlik City Hospital, Turkey.

Dr. Tuğba Ağbal is a dedicated specialist in obstetrics and gynecology, currently serving at Etlik City Hospital. She completed her residency at The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital and earned her medical degree from Gazi University Faculty of Medicine. Dr. Ağbal’s professional experience includes significant roles at both Etlik City Hospital and Bulanık Public Hospital. Her research interests focus on reproductive health, prenatal and postnatal care, and innovative surgical techniques. She has received multiple awards and honors, including competency certificates in laparoscopic and hysteroscopic interventions, obstetric ultrasonography, neonatal resuscitation, and various therapeutic practices. Dr. Ağbal’s research skills are robust, encompassing clinical study design, statistical analysis, literature review, and collaboration. Her contributions to women’s health are marked by her compassionate approach to patient care and her commitment to advancing medical knowledge and improving clinical outcomes.

Professional Profiles:

Education 🎓

Tuğba Ağbal completed her Obstetrics and Gynecology Residency at The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital in Ankara, Turkey, from 2016 to 2021. Prior to her residency, she earned her medical degree from Gazi University Faculty of Medicine, also in Ankara, where she studied from 2009 to 2015. Her educational journey began at Hacı Ömer Tarman Science High School in Ankara, where she completed her high school education from 2005 to 2009.

Professional Experience

Since February 2023, Tuğba Ağbal has been working as a specialist in the Obstetrics and Gynecology Clinic at Etlik City Hospital. Prior to this, she served as a specialist in the Obstetrics and Gynecology Clinic at Bulanık Public Hospital from 2022 to 2023. Her professional journey has been marked by a dedication to women’s health, with a focus on providing comprehensive care in obstetrics and gynecology. During her tenure at these hospitals, she has gained extensive experience in managing a variety of cases, ranging from routine prenatal and postnatal care to complex gynecological surgeries. Dr. Ağbal’s commitment to her field is evident through her continuous pursuit of professional development and her active involvement in clinical practice, ensuring she stays at the forefront of medical advancements. Her work is characterized by a compassionate approach to patient care and a strong commitment to improving women’s health outcomes.

Research Interest

Tuğba Ağbal’s research interests are primarily focused on obstetrics and gynecology, with a particular emphasis on improving clinical outcomes and advancing medical knowledge in women’s health. She is deeply interested in the study of reproductive health, prenatal and postnatal care, and the management of gynecological disorders. Her work includes investigating innovative approaches to treat conditions such as pelvic floor organ prolapse and postpartum complications. Additionally, she is keen on exploring the impacts of various medical interventions on maternal and fetal health. Dr. Ağbal is also interested in the development and assessment of new methodologies for gynecological surgeries and minimally invasive techniques. Her research aims to enhance the understanding and treatment of female reproductive health issues, contributing to better patient care and outcomes.

Award and Honors

Tuğba Ağbal has received several awards and honors throughout her career. She was awarded the Laparoscopic Intervention Competency Achievement Certificate from The University of Health Sciences Etlik Zübeyde Hanım Gynecology Training and Research Hospital in Ankara, Turkey. She also earned the Hysteroscopic Intervention Competency Achievement Certificate from the same institution. Additionally, Dr. Ağbal completed training and received competency certification for basic obstetric ultrasonography in both the first and second trimesters. She has been recognized for her expertise in neonatal resuscitation by the Turkish Ministry of Health, General Directorate of Public Health, Department of Child and Adolescent Health. Furthermore, she holds certifications in colposcopy, divorce therapy, sexual therapy, and marriage and couple therapy from the Relationship Therapies Institute. These accolades highlight her dedication to professional development and excellence in her field.

Research Skills

Tuğba Ağbal possesses a comprehensive set of research skills that enhance her expertise in obstetrics and gynecology. She is proficient in designing and conducting clinical studies, particularly those related to women’s reproductive health. Her skills include statistical analysis and data interpretation, which are crucial for evaluating research outcomes and drawing meaningful conclusions. Dr. Ağbal is experienced in writing and reviewing scientific manuscripts, contributing to her ability to publish research findings in reputable journals. She is adept at using various research methodologies, including both qualitative and quantitative approaches, to explore complex medical issues. Additionally, her skills in literature review and meta-analysis enable her to synthesize existing research and identify gaps in knowledge. Dr. Ağbal’s ability to collaborate with multidisciplinary teams and her commitment to ethical research practices further underscore her capabilities as a researcher in the field of obstetrics and gynecology.